Carlsmed today announced it has appointed Sharon Schulzki as its chief operating officer.
Schulzki has experience in building venture-backed medtech startups and has held a number of leadership roles at Stryker and Johnson & Johnson.
“We’ve made tremendous progress during the last year, and today I’m pleased to announce that Sharon has joined the team as COO,” CEO and cofounder Mike Cordonnier said in a news release. “Sharon’s track record of building value through execution of evidence development plans and key surgeon engagement will ensure that Carlsmed’s platform achieves the mission of making personalized medical devices the preferred treatment option.”
Carlsbad is currently using AI and predictive analytics to personalize adult spinal deformities treatment.
“Carlsmed is utilizing the vast diagnostic and outcomes data that we as surgeons collect about our patients to create the optimal devices for each new patient on demand,” Chris Ames, advisor to Carlsmed, said. “This should be the new standard of care for treatment of complex adult spine disorders and beyond – and Sharon is the right person to execute on the vision.”